Changes in the national prevalence of asthma and coronavirus disease 2019 fatality

Bedolla-Barajas, Martín; Morales-Romero, Jaime; Robles-Figueroa, Martín; Delgado-Figueroa, Tonatiuh

doi:10.1016/j.anai.2023.04.028

Cited by 2 publications

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Allergic disorders such as atopic dermatitis (AD) are most commonly observed in children but are increasingly recognized as a cause of significant morbidity and have long-term effects even in adults, leading to impaired quality of life and economic burden [1]. While the COVID-19 pandemic has brought unprecedented challenges to healthcare systems, its specific impact on the prevalence of AD among adults remains unexplored [2,3]. Pandemic-related factors such as increased handwashing, utilization of personal protective equipment, and elevated psychosocial stress could be potential modifiers for the development and symptoms of AD; however, studies exploring the impact of the pandemic on the prevalence of AD among adults are lacking [4,5].…”

Section: Introductionmentioning

confidence: 99%

National Trends and Prevalence of Atopic Dermatitis and Pandemic-Related Factors among Korean Adults, 2007–2021

Kang,

Park,

Lee

et al. 2024

Int Arch Allergy Immunol

View full text Add to dashboard Cite

Introduction: Previous studies have variably reported inconclusive trends in the prevalence of atopic dermatitis (AD) among adults, and there are limited data on the impact of the COVID-19 pandemic. We aimed to investigate the national trends and age-stratified prevalence of AD among adults from 2007 to 2021 in South Korea, focusing mainly on the impact of the COVID-19 pandemic-related factors. Methods: A nationwide cross-sectional study was conducted using the Korea National Health and Nutrition Examination Survey data from 2007 to 2021. Overall and age-stratified prevalence for AD were assessed using weighted beta coefficients or odds ratios. Results: A total of 83,566 adults over 20 years (male, 49.40%) were included. During the observation period, the prevalence of AD was stable in the overall population from 2.61% (95% CI, 2.29–2.93) in 2007–2009 to 2.15% (1.68–2.63) in 2020 and 2.38% (1.81–2.95) in 2021. However, the weighted prevalence of AD in adults aged 40–59 years old decreased during the pre-pandemic era, and the prevalence of AD in adults aged above 60 years significantly decreased during the pandemic, with a significant decline observed after the initial outbreak. From age-stratification analysis, the adults aged 40–59 years showed a significant increase after the pandemic outbreak which was evident in specific variables: individuals with rural residence, lower education, and lower household income quartiles. Adults aged above 60 years showed a significant decrease in the slope after the outbreak, evident in specific variables: individuals of female, rural residence, lower education, and lower household income quartiles. Conclusion: We observed a stable overall prevalence of AD throughout the 15-year observation period. However, the age-stratified analysis suggested significantly different trends according to age-stratified groups and the impact of the COVID-19 pandemic on the prevalence of AD.

show abstract